Comparison Between Optimal Coherence Tomography Guidance and Angiography Guidance in Percutaneous Coronary Intervention (COCOA)
|ClinicalTrials.gov Identifier: NCT03176810|
Recruitment Status : Active, not recruiting
First Posted : June 6, 2017
Last Update Posted : June 6, 2017
|Condition or disease||Intervention/treatment|
|Coronary Disease||Device: OCT Device: Angiography|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||550 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Primary Purpose:||Device Feasibility|
|Official Title:||Comparison Between Optimal Coherence Tomography Guidance and Angiography Guidance in Percutaneous Coronary Intervention|
|Actual Study Start Date :||April 1, 2017|
|Estimated Primary Completion Date :||June 30, 2018|
|Estimated Study Completion Date :||June 30, 2019|
Active Comparator: OCT-guided PCI
PCI is performed by OCT guidance.
OCT is used to guide PCI.
Active Comparator: Angiography-guided PCI
PCI is performed by angiography guidance alone.
Angiography is used to guide PCI.
- Minimum stent area [ Time Frame: Immediately after PCI ]Minimum stent area is measured by OCT
- Target vessel failure [ Time Frame: 12-month afte PCI ]Target vessel failure is defined as a composite of cardiac death, target-vessel related myocardial infarction, and ischaemia-driven target vessel revascularisation
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03176810
|Department of Cardiovascular Medicine, Wakayama Medical University|
|Wakayama, Japan, 6418509|
|Principal Investigator:||Takashi Akaska, MD||Wakayama Medical University|